Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07443202
Brief Summary:
To evaluate lotilaner treatment in patients with ocular rosacea.
Detailed Description:
To evaluate safety of lotilaner compared to vehicle control in the treatment of ocular rosacea.
Study:
NCT07443202
Study Brief:
Protocol Section:
NCT07443202